RALBP1 and familial pancreatic carcinoma: In conclusion, these findings from the present study regarding the role of RLIP76 in survival and chemo-radiotherapy resistance of pancreatic cancer can potentially impact the translational research for the development of more effective and targeted therapeutic strategies for pancreatic cancer.